NCT00896376 arm group 094b29cee867407552635ebcaf13f8c8 [clinicaltrials_resource:NCT00896376/arm-group/094b29cee867407552635ebcaf13f8c8]
trastuzumab [clinicaltrials_resource:00291e36a9aa0522449eda6cdeb9bcf0]pharmacological study [clinicaltrials_resource:939f8b7a95c02ed26c279abeaf27d1a5]laboratory biomarker analysis [clinicaltrials_resource:cc99467a627d861f1c43ce9c8ed4c4b8]Trastuzumab in Treating Women With Metastatic Breast Cancer [clinicaltrials:NCT00896376]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00896376 arm group 094b29cee867407552635ebcaf13f8c8 [clinicaltrials_resource:NCT00896376/arm-group/094b29cee867407552635ebcaf13f8c8]
Bio2RDF identifier
NCT00896376/arm-group/094b29cee867407552635ebcaf13f8c8
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 4b29cee867407552635ebcaf13f8c8
identifier
clinicaltrials_resource:NCT00896376/arm-group/094b29cee867407552635ebcaf13f8c8
title
NCT00896376 arm group 094b29cee867407552635ebcaf13f8c8
@en
type
label
NCT00896376 arm group 094b29ce ...... b29cee867407552635ebcaf13f8c8]
@en